Fresenius gets warned after FDA inspection

The FDA has sent a warning letter to Fresenius Medical Care Holdings that states its facilities used to produce kidney dialysis devices don't conform to agency standards. The FDA said the findings in the letter followed an inspection of the Waltham, MA-based company's plant between June 15 and August 6, 2010. Warning letter | Report

Suggested Articles

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.